RLFTY (Relief Therapeutics Holding) Days Sales Outstanding : 35.56 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Relief Therapeutics Holding Days Sales Outstanding?

Relief Therapeutics Holding's average Accounts Receivable for the six months ended in Jun. 2024 was $1.22 Mil. Relief Therapeutics Holding's Revenue for the six months ended in Jun. 2024 was $6.24 Mil. Hence, Relief Therapeutics Holding's Days Sales Outstanding for the six months ended in Jun. 2024 was 35.56.

The historical rank and industry rank for Relief Therapeutics Holding's Days Sales Outstanding or its related term are showing as below:

RLFTY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.57 Med: 77.05 Max: 143.1
Current: 44.57

During the past 13 years, Relief Therapeutics Holding's highest Days Sales Outstanding was 143.10. The lowest was 44.57. And the median was 77.05.

RLFTY's Days Sales Outstanding is ranked better than
73.7% of 867 companies
in the Biotechnology industry
Industry Median: 70.71 vs RLFTY: 44.57

Relief Therapeutics Holding's Days Sales Outstanding declined from Jun. 2023 (69.10) to Jun. 2024 (35.56).

Relief Therapeutics Holding Days Sales Outstanding Historical Data

The historical data trend for Relief Therapeutics Holding's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Days Sales Outstanding Chart

Relief Therapeutics Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

143.13

79.18

72.52

Relief Therapeutics Holding Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															68.42	75.17	69.10	64.96	35.56

Competitive Comparison of Relief Therapeutics Holding's Days Sales Outstanding

For the Biotechnology subindustry, Relief Therapeutics Holding's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Relief Therapeutics Holding's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's Days Sales Outstanding falls into.

Relief Therapeutics Holding Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Relief Therapeutics Holding's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.418	+	1.354)	/	2 )	/	6.976	*	365
=	1.386					/	6.976	*	365
=	72.52

Relief Therapeutics Holding's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (1.354	+	1.079)	/	2 )	/	6.244	*	365 / 2
=	1.2165					/	6.244	*	365 / 2
=	35.56

Relief Therapeutics Holding (OTCPK:RLFTY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Relief Therapeutics Holding Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

RLFTF:USA RLFz:UK 0QKQ:UK RLF:Switzerland

Address

Avenue de Secheron 15, Geneva, CHE, 1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development such as RLF-TD011, and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast among others. Geographically the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.